TUCSON, Ariz., Feb. 6 /PRNewswire-FirstCall/ -- Ventana Medical Systems,
Inc. (Nasdaq: VMSI), a leading supplier of automated instrument reagent
systems to histology labs and drug discovery labs worldwide, today announced
that it will hold a conference call on Friday, February 8, 2002, at 10:00 a.m.
EST to discuss its fourth-quarter and year-end financial and operating
results. The call can be accessed via the Internet live and as a replay at
http://www.vcall.com . The webcast will be available for replay for a period of 30
days.
Ventana develops, manufactures and markets instrument/reagent systems that
automate tissue preparation and slide staining in clinical histology and drug
discovery laboratories worldwide. Ventana's clinical systems are important
tools used in the diagnosis and treatment of cancer and infectious diseases.
Ventana's drug discovery systems are used to accelerate the discovery of new
drug targets and evaluate the safety of new drug compounds.
For more information on Ventana Medical Systems visit http://www.ventanamed.com
The Molecular Discovery Systems Division has its own website
at http://www.ventanadiscovery.com
SOURCE Ventana Medical Systems, Inc.
 back to top
Related links:
http://www.ventanamed.com
http://www.ventanadiscovery.com
CONTACT:
Christopher Gleeson, President and CEO of
Ventana Medical Systems, Inc., +1-520-229-3787, or Analysts,
Kathy Brunson of FRB Weber Shandwick, +1-312-640-6696
|
